Project Grant R34DA061263
Award Date
8/15/24
Completion Date
7/31/26
Dollars Obligated
$392K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...
This federal Project Grant award of $360,000.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop methods for assessing the effects of social isolation and loneliness during early life on neurocognitive function and addictive behavior in adolescent and adult rats. The research team from Old Dominion University (ODU) and the ODU Research Foundation (Odurf) will employ a rat model comparing the impacts of single...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding research to investigate the molecular mechanisms underlying astrocytic CREB's regulation of cocaine drug-seeking behavior. The $180,646 award, spanning from December 2024 to November 2029, will be conducted by the Icahn School of Medicine at Mount Sinai. The research aims to elucidate the transcriptional and epigenetic regulation of astrocytes in...
This $284,040 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to conduct integrated single-cell and spatial mapping of the habenula circuitry to identify projection-specific molecular pathways associated with opioid exposure. The Lieber Institute for Brain Development in Baltimore, MD will lead this research effort from September 1, 2024 to August 31, 2026. The project will generate a...
This Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to model and modulate neural responses to reward and threat, and their associations with childhood adversity and substance use disorder (SUD) risk. The award, totaling $196,560, aims to identify multivariate neurosignatures predictive of problematic substance use in adolescence, elucidate the specificity of links between trauma type...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), provides $180,606 to the Icahn School of Medicine at Mount Sinai to conduct research on cocaine-induced proteomic changes in the nucleus accumbens and their role in addiction behaviors. The 5-year project aims to elucidate the cell-type and circuit-specific synaptic proteome changes in response to cocaine, with the goal of identifying potential...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $201,250 to New York University (NYU) to characterize the synaptic organization and connectivity of cholinergic interneurons in the nucleus accumbens core (NAc core) region of the mouse brain. The project aims to use anatomical, electrophysiological, and optogenetic techniques to investigate how diverse excitatory and inhibitory inputs contact...
This Project Grant award of $1,383,618 from the National Institute on Drug Abuse (NIDA) under CFDA Program 93.279 - Drug Use and Addiction Research Programs supports research to investigate the microglia-mediated adverse effects of cannabis (specifically Delta-9-tetrahydrocannabinol or THC) on prefrontal cortex maturation and cognitive function during adolescence. The research aims to: 1) identify the time course of cannabinoid receptor type 1 (CNR1)-mediated molecular and morphological...
This Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a randomized clinical trial to evaluate the effectiveness of cognitive skills training interventions in improving outcomes for offenders with substance use disorders. The $3,226,170 award, with a project period from September 30, 2024 to May 31, 2029, aims to validate prior findings that matching specific cognitive-emotional deficits in...
This Project Grant award of $207,910 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a 3-year training program for a graduate student at the University of Michigan to research shared neurobiological mechanisms that can confer vulnerability to addiction and comorbid psychiatric disorders such as post-traumatic stress disorder. The project will utilize chemogenetic and fiber photometry techniques to examine the...